不同型号角膜塑形镜控制儿童低度近视效果比较

谢龙堂; 吕太亮; 吴慧; 张萌; 胡媛媛; 林潇; 张诚诚; 吴建峰; 毕宏生

doi:10.16835/j.cnki.1000-9817.2021.12.033

不同型号角膜塑形镜控制儿童低度近视效果比较

doi: 10.16835/j.cnki.1000-9817.2021.12.033

谢龙堂¹,
吕太亮²,
吴慧²,
张萌²,
胡媛媛²,
林潇²,
张诚诚²,
吴建峰^{1, 2, ,},
毕宏生^{1, 2, ,}

1.
山东中医药大学眼科与视光医学院, 济南 250014
2.
山东省中西医结合眼病防治重点实验室/山东省高校中西医结合眼病防治技术重点实验室/山东中医药大学眼科研究所/山东中医药大学附属眼科医院/山东省眼视光与青少年视力低下防控临床医学研究中心/山东省视觉智能工程技术研究中心/山东省儿童青少年健康与近视防控研究院

基金项目:

国家重点研发计划项目 2019YFC1710202

国家重点研发计划项目 2019YFC1710203

详细信息

作者简介:
谢龙堂(1995-), 男, 山东临沂人, 硕士, 主要从事白内障与屈光不正防治研究工作

通讯作者:
吴建峰, E-mail: wujianfengrun@126.com

毕宏生, E-mai: hongshengbi@126.com

利益冲突声明 所有作者声明无利益冲突
中图分类号: R778.11 R778.3
计量
- 文章访问数: 694
- HTML全文浏览量: 344
- PDF下载量: 51
- 被引次数: 0
出版历程
- 收稿日期: 2021-03-15
- 修回日期: 2021-05-25
- 网络出版日期: 2021-12-23
- 刊出日期: 2021-12-25

Comparison of different orthokeratology lenses in controlling the progression of low-myopia in children

1.
Medical College of Optometry and Ophthalmology, Shandong University of Traditional Chinese Medicine, Jinan (250014), China

摘要

摘要: 目的比较不同型号角膜塑形镜控制儿童低度近视的效果，为探讨保护儿童视力的有效防治措施提供参考。方法收集前往山东中医药大学附属眼科医院就诊的8~12岁初次佩戴角膜塑形镜患者的资料175例(350只眼)，回顾性分析佩戴Mouldway，Alpha，Lucid，CRT 4种不同型号角膜塑形镜1年后眼轴长度(AL)和等效球镜度(SER)变化的差异，分析眼AL变化量、SER变化量与性别、年龄的关系。结果 Mouldway组、Alpha组、Lucid组和CRT组AL变化量M(P₂₅，P₇₅)分别为0.23(0.12，0.41)、0.30(0.17，0.45)、0.35(0.16，0.41)和0.33(0.23，0.41)mm，差异无统计学意义(Z=7.70，P>0.05)；4组SER变化量M(P₂₅，P₇₅)分别为-0.31(-1.00，0.28)、-0.38(-1.22，0.13)、-0.25(-0.84，0.13)和-0.63(-1.13，0.25)D，差异无统计学意义(Z=2.15，P>0.05)。年龄与AL变化量呈负相关(r=-0.26，P < 0.05)，与SER变化量相关无统计学意义(r=0.10，P>0.05)。不同性别儿童AL变化量(Z=-2.25)和SER变化量(Z=-1.50)差异均无统计学意义(P值均>0.05)。结论不同型号角膜塑形镜在控制低度近视儿童眼轴增长和改变眼球屈光状态效果没有显著差异。
- 角膜塑形术 /
- 眼镜 /
- 近视 /
- 儿童
Abstract: Objective To compare the effect of different orthokeratology lenses in controlling the progression of low-myopia in children, and to provide a reference for exploring effective prevention measures for eyesight of children. Methods A total of 175 cases (350 eyes) aged 8-12 years old who were fitted with orthokeratology lenses were collected in this retrospective study. The differences in the changes of the axis length (AL) and the spherical equivalent refraction (SER) were analyzed after wearing different orthokeratology lenses for one year, and the relationship between the change of AL, SER and gender, age was also analyzed. Results In the Mouldway group, Alpha group, Lucid group and CRT group, the Median (P₂₅, P₇₅) of AL changes were 0.23 (0.12, 0.41), 0.30 (0.17, 0.45), 0.35 (0.16, 0.41) and 0.33 (0.23, 0.41)mm, and there were no statistical significant difference between four groups (Z=7.70, P>0.05); The Median (P₂₅, P₇₅) of SER changes were -0.31 (-1.00, 0.28), -0.38 (-1.22, 0.13), -0.25 (-0.84, 0.13) and -0.63 (-1.13, 0.25)D, and there were no statistical significant difference between four groups (Z=2.15, P>0.05). The age had negative correlation with the change of AL (r=-0.26, P < 0.05), but has nothing to do with the change of SER (r=0.10, P>0.05). There was no statistically significant difference in the change of AL (Z=2.25, P>0.05) and SER (Z=-1.50, P>0.05) among children of different genders. Conclusion Different orthokeratology lenses have no differences in controlling the growth of the AL and changing the SER.
- Orthokeratologic procedures /
- Eyeglasses /
- Myopia /
- Child
注释:

1) 利益冲突声明 所有作者声明无利益冲突

HTML全文

表 1 4种角膜塑形镜参数

Table 1. Parameters of the Ortho-K lenses

名称	设计	材料	湿润角/(°)	透光率/%	折射率/%	中心厚度/mm
Mouldway	VST	Boston XO	49	87	1.42	0.24
Alpha	VST	Boston EM	35	85	1.42	0.22
Lucid	VST	Boston XO	49	87	1.42	0.23
CRT	CRT	HDS100	42	95	1.44	0.16
注：VST(vision shaping treatment，视觉塑形治疗)，CRT(corneal refractive therapy，角膜屈光疗法)。

下载: 导出CSV

表 2 配戴不同型号角膜塑形镜儿童AL、SER比较[M(P₂₅，P₇₅)]

Table 2. Comparison of data for different groups of children [M(P₂₅, P₇₅)]

组别	人数	AL基线/mm	SER基线/D	AL变化量/mm	SER变化量/D
Mouldway	55	24.36(23.74，25.03)	-2.00(-2.25，-1.50)	0.23(0.12，0.41)	-0.31(-1.00，0.28)
Alpha	42	24.14(23.69，24.73)	-2.25(-2.72，-1.75)	0.30(0.17，0.45)	-0.38(-1.22，0.13)
Lucid	30	24.50(23.86，24.80)	-1.88(-2.25，-1.50)	0.35(0.16，0.41)	-0.25(-0.84，0.13)
CRT	48	24.22(23.77，24.83)	-1.94(-2.50，-1.50)	0.33(0.23，0.41)	-0.63(-1.13，0.25)
Z值		4.69	1.78	7.70	2.15
P值		0.20	0.62	0.05	0.54

下载: 导出CSV

参考文献(16)

[1]	FU A C, QIN J, RONG J B, et al. Effects of orthokeratology lens on axial length elongation in unilateral myopia and bilateral myopia with anisometropia children[J]. Cont Lens Anterior Eye, 2020, 43(1): 73-77. doi: 10.1016/j.clae.2019.12.001
[2]	李霞, 张茂菊, 宋秀胜. 青少年近视长期配戴角膜塑形镜的有效性和安全性[J]. 国际眼科杂志, 2018, 18(5): 968-970. LI X, ZHANG M J, SONG X S. Observation on the long-term effectiveness and safety of juvenile myopia patients wearing orthokeratology[J]. Int Eye Sci, 2018, 18(5): 968-970.
[3]	李雪娇, 尹洁, 朱勤, 等. 单眼低度近视患儿佩戴角膜塑形镜及框架眼镜对屈光度的影响[J]. 中国学校卫生, 2021, 42(1): 109-111. doi: 10.16835/j.cnki.1000-9817.2021.01.026 LI X J, YIN J, ZHU Q, et al. Effects of orthokeratology lenses and frame glasses on anisometropia in primary and middle school students with low myopia in one eye[J]. Chin J Sch Health, 2021, 42(1): 109-111. doi: 10.16835/j.cnki.1000-9817.2021.01.026
[4]	魏士飞, 李仕明, 孙芸芸, 等. 角膜塑形镜对低中度近视儿童眼球生物学参数的影响[J]. 中华眼视光学与视觉科学杂志, 2017, 19(9): 548-553. doi: 10.3760/cma.j.issn.1674-845X.2017.09.006 WEI S F, LI S M, SUN Y Y, et al. Effects of orthokeratology lenses on ocular biometric parameters in children with low to moderate myopia[J]. Chin J Optom Ophthalmol Vis Sci, 2017, 19(9): 548-553. doi: 10.3760/cma.j.issn.1674-845X.2017.09.006
[5]	郑杰, 张钰, 陈跃国, 等. 基线近视屈光度对角膜塑形镜控制青少年儿童近视进展的影响[J]. 中华眼视光学与视觉科学杂志, 2018, 20(10): 582-587. doi: 10.3760/cma.j.issn.1674-845X.2018.10.002 ZHENG J, ZHANG Y, CHEN Y G, et al. Influence of baseline myopic refraction on myopia control in youngsters wearing orthokeratology lenses[J]. Chin J Optom Ophthalmol Vis Sci, 2018, 20(10): 582-587. doi: 10.3760/cma.j.issn.1674-845X.2018.10.002
[6]	王华德, 张清生. 角膜塑形镜控制少年近视发展的效果观察[J]. 中华眼外伤职业眼病杂志, 2019, 41(12): 946-949. doi: 10.3760/cma.j.issn.2095-1477.2019.12.014 WANG H D, ZHANG Q S. Observation on the efficacy of orthokeratology lens for the control of myopia of juvenile[J]. Chin J Ocul Traum Occup Eye Dis, 2019, 41(12): 946-949. doi: 10.3760/cma.j.issn.2095-1477.2019.12.014
[7]	艾欣, 张学辉, 叶璐. 角膜塑形镜控制青少年近视有效性及安全性的Meta分析[J]. 中华眼视光学与视觉科学杂, 2019, 21(2): 127-134. doi: 10.3760/cma.j.issn.1674-845X.2019.02.009 AI X, ZHNAG X H, YE L. Efficacy and safety of orthokeratology for slowing myopia progression in children: a meta-analysis study[J]. Chin J Optom Ophthalmol Vis Sci, 2019, 21(2): 127-134. doi: 10.3760/cma.j.issn.1674-845X.2019.02.009
[8]	LI Z Y, CUI D M, HU Y, et al. Choroidal thickness and axial length changes in myopic children treated with orthokeratology[J]. Cont Lens Anter Eye, 2017, 40(6): 417-423. doi: 10.1016/j.clae.2017.09.010
[9]	杨培增, 范先群. 眼科学[M]. 北京: 人民卫生出版社, 2019: 217-236. YANG P Z, FAN X Q. Ophthalmology[M]. Beijing: People's Medical Publishing House, 2019: 217-236.
[10]	WILDSOET C F, CHIA A, CHO P, et al. IMI-interventions myopia institute: interventions for controlling myopia onset and progression report[J]. Invest Ophthalmol Vis Sci, 2019, 60(3): M106-M131. doi: 10.1167/iovs.18-25958
[11]	LEE Y C, WANG J H, CHIU C J. Effect of orthokeratology on myopia progression: twelve-year results of a retrospective cohort study[J]. BMC Ophthalmol, 2017, 17(1): 243. doi: 10.1186/s12886-017-0639-4
[12]	LIPSON M J, BROOKS M M, KOFFLER B H. The role of orthokeratology in myopia control: a review[J]. Eye Contact Lens, 2018, 44(4): 224-230. doi: 10.1097/ICL.0000000000000520
[13]	SMITH E L. Prentice award lecture 2010: a case for peripheral optical treatment strategies for myopia[J]. Optom Vis Sci, 2011, 88(9): 1029-1044. doi: 10.1097/OPX.0b013e3182279cfa
[14]	QUEIROS A, AMORIM-DE-SOUSA A, LOPE-FERREIRA D, et al. Relative peripheral refraction across 4 meridians after orthokeratology and LASIK surgery[J]. Eye Vis (Lond), 2018, 5: 12. doi: 10.1186/s40662-018-0106-1
[15]	CHEN R R, YU J J, LIPSON M, et al. Comparison of four different orthokeratology lenses in controlling myopia progression[J]. Cont Lens Anter Eye, 2020, 43(1): 78-83. doi: 10.1016/j.clae.2019.11.012
[16]	WOLFFSOHN J S, KOLLBAUM P S, BERNTSEN D A, et al. IMI-Clinical myopia control trials and instrumentation report[J]. Invest Ophthalmol Vis Sci, 2019, 60(3): M132-M160.